Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine withi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Médiavilla, Clémence, Yon, Edwige, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Forcade, Edouard, Milpied, Noël, Sarry, Audrey, Sauvezie, Mathieu, Bories, Pierre, Pigneux, Arnaud, Récher, Christian
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Clinical Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668025/
https://ncbi.nlm.nih.gov/pubmed/29108292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15988
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki